MeSH tree: D12.776.220.600.450
The first drug that can slow the rate of decline in Alzheimer's patients has been found. The experimental drug, called lecanemab, is an antibody that targets the toxic clumps of amyloid protein associated with the mind-robbing ...
Dec 2, 2022
0
52
Researchers from an Indiana University School of Medicine-led consortium of Alzheimer's disease experts are studying how an anti-seizure drug used to treat epilepsy in children and adults could be repurposed as a potential ...
Nov 30, 2022
0
62
The brain's big-eating immune cells can slow down the progression of Alzheimer's disease. This is shown by a study that is now published in Nature Aging.
Nov 29, 2022
0
80
Researchers from Indiana University School of Medicine have identified a protein that interacts and enhances the spread of neurotoxic species of tau—which is primarily found in neurons that appear abnormal in the brains of ...
Nov 17, 2022
0
122
Memory loss is often the first sign of Alzheimer's disease, followed by confusion and difficulty thinking. These symptoms reflect the typical pattern of worsening damage to brain tissues. Toxic clusters of proteins first ...
Nov 16, 2022
0
607
In March 1946, just months after the end of the second world war, James Douglas began a pioneering and extraordinary study. Based on a representative sample of 5,362 babies all born in the same week of that month, the study ...
Nov 14, 2022
0
52
A large study led by Lund University in Sweden has shown that people with Alzheimer's disease can now be identified before they experience any symptoms. It is now also possible to predict who will deteriorate within the next ...
Nov 11, 2022
0
233
The clean-up of cellular "protein clumps" could prevent the onset of some types of dementia, according to a new study from The University of Queensland.
Nov 7, 2022
0
97
Indiana University School of Medicine researchers are investigating how the deficiency of a gene in immune cells can shape the progression of Alzheimer's disease.
Nov 3, 2022
0
90
Scientists at the UNC School of Medicine and UNC Eshelman School of Pharmacy, in collaboration with a team from Queen Mary University of London, have illuminated the molecular events underlying an inherited movement and ...
Nov 3, 2022
0
151
